Holen Sie sich die Stockscreener-App
57.65
0.83%
-0.6039
Schlusskurs vom Vortag:
$58.25
Offen:
$58.84
24-Stunden-Volumen:
92,435
Relative Volume:
0.06
Marktkapitalisierung:
$1.65B
Einnahmen:
$911.98M
Nettoeinkommen (Verlust:
$145.42M
KGV:
11.61
EPS:
4.9642
Netto-Cashflow:
$78.48M
1W Leistung:
-8.29%
1M Leistung:
-3.34%
6M Leistung:
-27.84%
1J Leistung:
-63.63%
1-Tages-Spanne:
$57.58
$60.00
1-Wochen-Bereich:
$57.46
$62.51
52-Wochen-Spanne:
$53.11
$172.95
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
57.61 | 1.67B | 911.98M | 145.42M | 78.48M | 4.9642 |
|
ABT
Abbott Laboratories
|
108.27 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.13 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.70 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.58 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.19 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Systems Q4 2025 slides: revenue hits $912M, projects slower growth - Investing.com Nigeria
Atika Capital Management LLC Buys 25,700 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical: Sleeping Giant Awakens The OSA Implant Market, Initiating With A Buy (NYSE:INSP) - Seeking Alpha
Inspire Medical Systems, Inc. $INSP Shares Sold by Intech Investment Management LLC - MarketBeat
Inspire Medical Systems Stock Analysis: Performance & Investor Outlook 2026News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? - TradingView
Inspire Medical Systems, Inc. $INSP Shares Purchased by WINTON GROUP Ltd - MarketBeat
Regal Partners Ltd Buys New Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Rhenman & Partners Asset Management AB Acquires 30,500 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Will Inspire Medical Systems Inc. stock benefit from AI adoption2025 Risk Factors & Stepwise Trade Signal Guides - Naître et grandir
Neo Ivy Capital Management Boosts Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
How Medicare Coding Shifts And Inspire V Launch At Inspire Medical Systems (INSP) Have Changed Its Investment Story - Yahoo Finance
Winners And Losers Of Q4: Inspire Medical Systems (NYSE:INSP) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) Given New $85.00 Price Target at Stifel Nicolaus - MarketBeat
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - TradingView
Inspire Medical Systems Hits Day High with 14.85% Surge in Stock Price - Markets Mojo
The Analyst Verdict: Inspire Medical Systems In The Eyes Of 17 Experts - Benzinga
Stifel Lowers Price Target for Inspire Medical Systems (INSP) to $85 | INSP Stock News - GuruFocus
Inspire Medical Systems, Inc. $INSP Shares Sold by Envestnet Asset Management Inc. - MarketBeat
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum - The Manila Times
Inspire Medical Systems (NYSE:INSP) Updates FY 2026 Earnings Guidance - MarketBeat
Quantbot Technologies LP Makes New Investment in Inspire Medical Systems, Inc. $INSP - MarketBeat
Why Inspire Medical Systems (INSP) Is Up 11.2% After CMS Clarifies Coding For Inspire V - simplywall.st
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - marketscreener.com
Inspire Medical Systems, Inc. $INSP Holdings Decreased by Vanguard Group Inc. - MarketBeat
Inspire Medical Systems, Inc. (INSP): Evaluating Growth Potential in the Medical Device Sector - DirectorsTalk Interviews
William Blair Investment Management LLC Has $96.28 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Artisan Partners Limited Partnership Grows Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Assessing Inspire Medical Systems (INSP) Valuation After New CMS Billing Codes For Sleep Apnea Therapy - Sahm
INSP SEC FilingsInspire Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Evercore ISI Maintains Outperform on INSP (Inspire Medical Systems) Feb 2026 - Meyka
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) Shares Gap DownHere's What Happened - MarketBeat
Inspire Medical Stock Rises on CMS Code Assignment for Sleep Apnea DeviceNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Assessing Inspire Medical Systems (INSP) Valuation After A Sharp Short Term Share Price Rebound - Yahoo Finance
Inspire Medical Systems Stock Rebounds 15%: What Q4 Profit Growth Means for 2026 - TIKR.com
Inspire Medical Systems jumps as CMS moves to add new billing codes that could ease reimbursement uncertainty - Quiver Quantitative
Inspire Medical surges after KeyBanc sees CMS adding codes for Inspire V implant - Seeking Alpha
Inspire Medical (INSP) Rises Following KeyBanc's Positive Note o - GuruFocus
Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why - TradingView
Inspire Medical (INSP) Jumps 33% Following New CMS Coding Announ - GuruFocus
Inspire Medical Systems (NYSE:INSP) Stock Price Up 33%What's Next? - MarketBeat
Does Inspire Medical Systems (INSP) Offer Value After Its Sharp One Year Share Price Slump - simplywall.st
Precision Trading with Inspire Medical Systems Inc. (INSP) Risk Zones - Stock Traders Daily
Inspire Medical Systems (INSP) Price Target Decreased by 27.11% to 95.55 - Nasdaq
Equity awards and tax withholding reported by Inspire Medical (INSP) officer - Stock Titan
[Form 4] Inspire Medical Systems, Inc. Insider Trading Activity - Stock Titan
Inspire Medical (INSP) executive gets major stock, RSU awards and tax withholding - Stock Titan
Inspire Medical (INSP) officer awarded shares, RSUs and tax withholding - Stock Titan
CFO Osberg reports 19,794 Inspire Medical (INSP) shares and RSUs - Stock Titan
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):